Cargando…
Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy
With the increasing usage of sensitive PCR technology for pharmacogenetics, cross contamination becomes a significant concern. Researchers employed techniques which basically include replacing laboratory equipment after each sample preparation; however, there are no recommended guidelines. In the pr...
Autores principales: | Asor, Eyal, Stav, Michael Y., Simon, Einav, Fahoum, Ibrahim, Sabo, Edmond, Ben-Izhak, Ofer, Hershkovitz, Dov |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348008/ https://www.ncbi.nlm.nih.gov/pubmed/28288198 http://dx.doi.org/10.1371/journal.pone.0173760 |
Ejemplares similares
-
Clinically significant sub-clonality for common drivers can be detected in 26% of KRAS/EGFR mutated lung adenocarcinomas
por: Simon, Einav, et al.
Publicado: (2017) -
Characterization of Factors Affecting the Detection Limit of EGFR p.T790M in
Circulating Tumor DNA
por: Fahoum, Ibrahim, et al.
Publicado: (2018) -
Variation in KRAS driver substitution distributions between tumor types is determined by both mutation and natural selection
por: Ostrow, Sheli L., et al.
Publicado: (2016) -
The incidence and prognostic value of HER2 overexpression and cyclin D1 expression in patients with gastric or gastroesophageal junction adenocarcinoma in Israel
por: BAR-SELA, GIL, et al.
Publicado: (2013) -
The risk of PD-L1 expression misclassification in triple-negative breast cancer
por: Ben Dori, Shani, et al.
Publicado: (2022)